Europe Minimally Invasive Surgical Instruments Market to Grow with a CAGR of 9.39% through 2030

Surging prevalence of chronic & age‑related diseases and expanding end‑user base & outpatient settings are factors driving the Europe Minimally Invasive Surgical Instruments market in the forecast period 2026-2030.

According to TechSci Research report, “Europe Minimally Invasive Surgical Instruments Market –Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030”, the Europe Minimally Invasive Surgical Instruments Market stood at USD 8.07 Billion in 2024 and is anticipated to grow with a CAGR of 9.39% in the forecast period, 2026-2030. Europe is experiencing rapid growth in chronic conditions—particularly cardiovascular disorders, Orthopaedic ailments, gastrointestinal issues, and cancer—driven by an aging population. Minimally invasive surgeries (MIS) are increasingly preferred for these indications due to benefits such as smaller incisions, reduced blood loss, faster recovery, and lower postoperative complications .

MIS enables significantly shorter hospital stays, reduced pain medication use, and faster patient turnover—all of which reduce costs for payers and hospitals . The shift toward ambulatory clinics for outpatient surgeries further supports increased device demand.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Europe Minimally Invasive Surgical Instruments Market”

Europe’s aging demographic (e.g. Germany, UK, France) drives a higher incidence of orthopedic, cardiovascular, and oncologic procedures—common applications for MIS . This growing demand fuels broader adoption and scale.

While hospitals currently dominate procedures, utilization at outpatient clinics and ambulatory surgery centers is growing at double-digit rates . Such settings benefit especially from handheld instruments and portable visuo-technical solutions.

The Europe Minimally Invasive Surgical Instruments Market is segmented into Instrument, Type, Application, End User, country and company.

Based on its end user, the Hospitals held the largest share of revenue in 2024. Hospitals remain the primary centers for performing a wide range of surgeries, including those requiring minimally invasive techniques. These procedures, such as laparoscopic surgeries, endoscopic interventions, and robotic-assisted surgeries, are commonly conducted in hospital settings where comprehensive diagnostic, surgical, and postoperative care can be provided under one roof. With the increasing prevalence of chronic diseases such as cancer, cardiovascular conditions, and gastrointestinal disorders, hospitals have witnessed a growing influx of patients requiring surgical intervention, thereby driving up demand for minimally invasive surgical (MIS) instruments.

Based on country, the United Kingdom segment is expected to grow during the forecast period, due to the country's strong healthcare infrastructure, high adoption of advanced medical technologies, and increasing focus on patient-centric, cost-effective treatments. The UK's National Health Service (NHS) continues to prioritize minimally invasive procedures as they are associated with shorter hospital stays, quicker recovery times, and reduced healthcare costs—factors that align with NHS objectives to optimize patient outcomes while managing public expenditure. The rising prevalence of chronic diseases such as cardiovascular conditions, obesity, cancer, and gastrointestinal disorders is leading to increased demand for surgical interventions. However, there is a growing preference for minimally invasive techniques over traditional open surgeries among both healthcare providers and patients. This preference is further reinforced by the growing awareness of the clinical benefits of MIS, such as reduced pain, lower infection risks, and minimal scarring. As a result, hospitals and surgical centers in the UK are increasingly investing in technologically advanced instruments such as laparoscopes, endoscopes, and robotic-assisted surgical systems..

Major companies operating in Europe Minimally Invasive Surgical Instruments Market are:

• Medtronic PLC
• Johnson & Johnson
• Stryker Corporation
• B. Braun Melsungen AG
• CONMED Corporation
• Smith & Nephew PLC
• Abbott Laboratories
• Zimmer Biomet Holdings, Inc.
• Boston Scientific Corporation
• Becton, Dickinson and Company
• HOYA Corporation
• The Cooper Companies, Inc.
• Surgical Innovations Group PLC
• Omniguide Holdings Inc
•  Applied Medical Resources Corporation

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 “The Europe MIS instruments market is being powered by demographic shifts, chronic disease prevalence, surgical innovation, and public healthcare investment. Although cost and workforce limitations pose challenges, accelerating advancements in robotics, imaging, and materials, coupled with expanding outpatient applications, will sustain robust growth through the end of the decade,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Europe Minimally Invasive Surgical Instruments Market - By Instrument (Endoscopes, Laparoscopy Access Instruments, Laparoscopy Handheld Instruments, Robotic Assisted Surgical Systems, Electrosurgery, Visualization and Monitoring System), By Type (Endoscopy, Laparoscopy, Robotics), By Application (Gynecology, Orthopedic Surgery, Respiratory, Oncology, Gastrointestinal, Urology, Cardiology, Others), By End-User (Hospitals, Surgical Centers, Others), By Country,  Competition Forecast & Opportunities, 2020-2030F”, has evaluated the future growth potential of Europe Minimally Invasive Surgical Instruments Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Europe Minimally Invasive Surgical Instruments Market.

Contact

TechSci Research LLC

420 Lexington Avenue,  Suite 300, New York, United States- 10170

Email: [email protected]

M: +13322586602